Syringaresinol Protects against Type 1 Diabetic Cardiomyopathy by Alleviating Inflammation Responses, Cardiac Fibrosis, and Oxidative Stress
Keyword(s):
2018 ◽
Vol 19
(10)
◽
pp. 3094
◽
2016 ◽
Vol 32
(3)
◽
pp. 329-336
◽
Keyword(s):
2008 ◽
Vol 62
(4)
◽
pp. 569-574
◽
Keyword(s):
2021 ◽
Vol Publish Ahead of Print
◽
Keyword(s):
2018 ◽
Vol 120
(2)
◽
pp. 2627-2633
◽